𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Prognostic factors for survival of small (≤5 cm) untreated hepatocellular carcinoma in the west

✍ Scribed by Bolondi, L.; Gaiani, S.; Fuaconi, F.; Rigamonti, A.; Barbara, L.

Book ID
123448489
Publisher
Elsevier Science
Year
1991
Tongue
English
Weight
74 KB
Volume
13
Category
Article
ISSN
0168-8278

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Natural history of small untreated hepat
Natural history of small untreated hepatocellular carcinoma in cirrhosis: A multivariate analysis of prognostic factors of tumor growth rate and patient survival
✍ Luigi Barbara; Giovanna Benzi; Stefano Gaiani; Fabio Fusconi; Gianni Zironi; Seb 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 690 KB

We analyzed the growth pattern of tumor masses and the survival of 39 asymptomatic Italian patients with a total of 59 small ( I 6 cm in diameter) hepatocellular carcinomas arising from cirrhosis. The total length of the observation period ranged from 90 to 962 days, with an average of 364 f 229 (me

Prognostic factors of hepatocellular car
Prognostic factors of hepatocellular carcinoma in the west: A multivariate analysis in 206 patients
✍ Xavier Calvet; Jordi Bruix; Pere Ginés; Concepció Bru; Manel Sole; Ramón Vilana; 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 718 KB

To investigate the prognostic factors in Western patients with hepatocellular carcinoma, 206 patients with condjrmed diagnoses of hepatocellular carcinoma were etadied in terms of survival. All patients were dialplosed between 1983 and 1987. A multivariate survival analysis (Cox regreesion model) us

Prognostic factors for survival in patie
Prognostic factors for survival in patients with compensated cirrhosis and small hepatocellular carcinoma after percutaneous ethanol injection therapy
✍ Maurizio Pompili; Gian Ludovico Rapaccini; Marcello Covino; Giulia Pignataro; Eu 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB 👁 3 views

## Background: The objective of this study was to identify clinical, biochemical, ultrasound, and/or pathologic parameters capable of predicting survival in a cohort of patients with well compensated cirrhosis and small hepatocellular carcinoma (hcc) who were treated with percutaneous ethanol injec